Error: Could not add to watchlist. X
+ Watchlist

Pharus SICAV - Biotech

PHARI2E:LX
Pending Listing
PHARI2E:LX is pending listing
EUR
Fund Type
SICAV
Before it's here, it's on the Bloomberg Terminal.
Learn More
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Multi
NAV (on -)
-
Total Assets (m EUR) (on 01/22/2018)
24.240
Inception Date
09/01/2017
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
-
Front Load Fee
-
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
-
Expense Ratio
-

Top Fund Holdings

Name Position Value % of Fund
13.97 k 1.62 m 8.38
11.66 k 1.46 m 7.52
8.19 k 1.26 m 6.48
18.95 k 1.20 m 6.21
3.15 k 805.52 k 4.16
21.20 k 796.82 k 4.11
2.05 k 742.38 k 3.83
6.42 k 727.52 k 3.75
6.65 k 680.10 k 3.51
18.65 k 679.81 k 3.51
Profile
Pharus SICAV - Biotech is an open-end fund incorporated in Luxembourg. The Fund's objective is achieve growth by investing in equities or similar securities issued by biopharmaceutical companies that are at the forefront of innovation in the medical sector. The Fund invests in diversified portfolio of securities issued by listed companies, government and corporate bonds
Address
Pharus Management Lux S.A.
16, avenue de la Gare
L-1610 Luxembourg
Phone
T. (+352) 28 55 69 - 20
Website
-